VJHemOnc is committed to improving our service to you

VJVirtual | Regulation: ATMP vs minimally manipulated immune cells

VJHemOnc is committed to improving our service to you

Christian Chabannon

Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, talks on the regulatory aspects of advanced therapy medicinal products (ATMP) versus minimally manipulated immune cells. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter